Charité - Universitätsmedizin Berlin

Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. (2022) Elhai M, Sritharan N, Boubaya M, Balbir-Gurman A, Siegert E, Hachulla E, de Vries-Bouwstra J, et al. Journal article Chronic Cough. (2022) Krüger K, Holzinger F, Trauth J, Koch M, Heintze C, Gehrke-Beck S Journal article [Process for the Implementation of Evidence-Based Parenteral Nutrition in German Perinatal Centres - Outcomes of a Multidisciplinary Network]. (2022) Hoffmann J, Haiden N, Babl J, Fusch C, Kostenzer J, Piening B, Schubert S, Mader S Journal article Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients. (2022) Koll CE, Hopff SM, Meurers T, Lee CH, Kohls M, Stellbrink C, Thibeault C, et al. Journal article Interpretable surface-based detection of focal cortical dysplasias: a Multi-centre Epilepsy Lesion Detection study (2022) Spitzer H, Ripart M, Whitaker K, D'Arco F, Mankad K, Chen AA, Napolitano A, et al. Journal article Integration of mobile sensors in a telemedicine hospital system: remote-monitoring in COVID-19 patients (2022) Muller A, Haneke H, Kirchberger V, Mastella G, Dommasch M, Merle U, Heinze O, et al. Journal article Correction to: Value of PET imaging for radiation therapy (Strahlentherapie und Onkologie, (2021), 197, 9, (1-23), 10.1007/s00066-021-01812-2) (2022) Lapa C, Nestle U, Albert NL, Baues C, Beer A, Buck A, Budach V, et al. Journal article, Erratum Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. (2022) Zanatta E, Huscher D, Ortolan A, Avouac J, Airo P, Balbir-Gurman A, Siegert E, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease (2022) Schneider I, Allner C, Mühl L, Melde M, Lissner D, Mantzivi E, Glauben R, et al. Journal article